How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Weight Loss Ingredients Market
- By Ingredient Type: Herbal Extracts, Dietary Fibers, Protein Supplements, Fat Burners, Appetite Suppressants, Thermogenic Agents
- By Formulation: Capsules & Tablets, Powders, Liquid Extracts, Functional Beverages, Snack Bars
- By Application: Dietary Supplements, Functional Foods, Pharmaceuticals, Sports Nutrition
- By Mechanism of Action: Metabolism Boosters, Fat Absorption Inhibitors, Appetite Control Agents, Energy Enhancers, Carbohydrate Blockers
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Herbal Extracts leads By Ingredient Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 284 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.169 →
- 11 Company Profiles 16 players: SWOT & benchmarking p.177 →
Full report · locked preview
Everything inside the Weight Loss Ingredients Market report
A complete, evidence-based study - 11 chapters and 119 sections covering market size, segmentation across 4 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Glanbia plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Herbalife Nutrition Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Amway Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Nutraceutical Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Naturex (a Givaudan company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →NOW Foods
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Sabinsa Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →BASF SE
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →DSM Nutritional Products
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Lonza Group AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Archer Daniels Midland Company
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Cargill
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Incorporated
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Chr. Hansen Holding A/S
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Kerry Group
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Balchem Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Herbal Extracts29.0
- Dietary Fibers17.6
- Protein Supplements12.0
- Fat Burners17.4
- Appetite Suppressants11.8
- Thermogenic Agents12.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Glanbia plc25.8
- Herbalife Nutrition Ltd.14.0
- Amway Corporation6.2
- Nutraceutical Corporation9.5
- Naturex (a Givaudan company)10.3
- NOW Foods6.2
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America36.2
- Europe21.3
- Asia Pacific19.7
- Latin America12.9
- Middle East and Africa9.9
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Glanbia plc | 79 | 85 | 80 | 85 | 79 | 89 | 83 |
| Herbalife Nutrition Ltd. | 86 | 91 | 77 | 80 | 79 | 91 | 84 |
| Amway Corporation | 86 | 71 | 77 | 76 | 83 | 67 | 77 |
| Nutraceutical Corporation | 57 | 63 | 74 | 79 | 79 | 63 | 69 |
| Naturex (a Givaudan company) | 65 | 65 | 70 | 64 | 65 | 64 | 66 |
| NOW Foods | 71 | 71 | 59 | 71 | 51 | 57 | 63 |
| Sabinsa Corporation | 47 | 52 | 61 | 62 | 63 | 54 | 57 |
| BASF SE | 39 | 50 | 60 | 38 | 43 | 54 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Glanbia plc
- Herbalife Nutrition Ltd.
- Amway Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Glanbia plc | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Herbalife Nutrition Ltd. | ✓ | ✓ | ✓ | ◐ | ✓ | ◐ |
| Amway Corporation | ✓ | ✓ | ✓ | ◐ | ✓ | − |
| Nutraceutical Corporation | − | − | ◐ | ◐ | ✓ | ◐ |
| Naturex (a Givaudan company) | ◐ | ✓ | ◐ | ◐ | − | ◐ |
| NOW Foods | ✓ | − | ◐ | ✓ | − | ◐ |
| Sabinsa Corporation | − | − | ◐ | ◐ | ✓ | ◐ |
| BASF SE | − | ◐ | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Challenger2
Strong scale, closing on the leaders.
Contender3
Focused players with pockets of strength.
Niche1
Specialists in a single segment or region.
Go-to-market strategy
Land Ingredient Type in North America, then scale across Weight Loss Ingredients Market — a $659M beachhead inside a $9.29B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Herbal Extracts
Best fit — highest urgency & budget in Ingredient Type.
Dietary Fibers
Strong fit — clear ROI and a fast path to value.
Protein Supplements
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Ingredient Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Formulation & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Ingredient Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Weight Loss Ingredients Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Weight Loss Ingredients Market is a durable-growth opportunity — $7.52B by 2033, compounding at 6.8%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.8% CAGR
Demand compounds through 2033, outpacing GDP across Ingredient Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Ingredient Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Formulation optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Weight Loss Ingredients Market — a $6.93B market by 2033. Plan: grow share from 11.3% to 18.9%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 11.3% | 18.9% | Ahead |
| Revenue | $845M | $1.31B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | At risk |
| Gross margin | 30.6% | 39.9% | Behind |
| Customer retention | 84.7% | 94.5% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Ingredient Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Formulation capability
A defensible second engine — invest in Formulation to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Ingredient Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Formulation
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $133M capacity & capability investment
- Greenlight bolt-on M&A in Formulation
- Authorise North America expansion plan
- Fund R&D program for Ingredient Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossBehind
- Input-cost & supply riskAhead
- Regulatory / policy changeAt risk
- Execution & talentAt risk
Sales deck · value proposition
Win the Weight Loss Ingredients Market conversation — a $1.22B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Ingredient Type
Goal Grow share in Ingredient Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Weight Loss Ingredients Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Weight Loss Ingredients Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Ceftriaxone Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportAlpha-Amylase Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportCeftriaxone Injection Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportCeftizoxime Sodium Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportCeftiofur Hydrochloride Injection Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportCefteram Pivoxil Tablets Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportCeftazidime Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportCeftazidime Avibactam Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportCeftazidime API Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportCefquinome Sulfate Injection Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportCefpodoxime Proxetil API Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportCefpirome Sulfate Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy